OBJECTIVES: To determine in the modern era if cardiopulmonary bypass (CPB) time has a significant effect on postoperative morbidity, mortality and long-term survival in patients undergoing isolated aortic valve replacement (AVR) surgery.
INTRODUCTION
Prolonged cardiopulmonary bypass (CPB) time is associated with increased morbidity and mortality [1] [2] [3] . Despite the enormous improvements in bypass safety secondary to technological improvements, morbidity and sometimes mortality can still be attributed to CPB.
Increasing a surgeon's operating speed may be counterproductive, due to the almost inevitable increase in technical errors that will ensue secondary to stress [4] [5] [6] . The introduction of rapid deployment aortic valves can potentially significantly reduce operating time and hence CPB times [7, 8] .
We investigated if, in the modern era, CPB times for isolated aortic valve replacement (AVR) were associated with increased morbidity and mortality.
METHODS
Local institutional review board permission was granted for this retrospective study. The study cohort was from 1 April 1997 to 30 March 2012 (Table 1) . Only patients undergoing first-time isolated AVR surgery were included at a single institution. Renal failure was defined as a preoperative serum creatinine >180 mmol/l or the need for preoperative dialysis (as per the EuroSCORE I scoring system) [9] . Valve pathology haemodynamically was defined as stenosis, regurgitation or mixed stenosis and regurgitation as defined based on preoperative echocardiography. Creatinine kinase muscle-brain isoenzyme (CKMB) was measured in all patients [10] . Continuous variables are presented as means (standard deviation [SD] ) [range] .
Bypass time
This was the total CPB time if more than one run on bypass existed. All patients with a cross-clamp time of >90 min were excluded to eliminate technical issues confounding the results. For statistical analysis, CPB time was treated as a continuous variable, but for graphical representation it was categorized as <60 min, 60 to <90 min, and ≥90 min.
Outcome measures
Primary outcomes analysed included resternotomy, CKMB release, mediastinal blood loss, intensive care unit (ICU) length of stay, hospital length of stay, in-hospital mortality and long-term survival. As previously described, the national strategic tracing service in the UK was utilized to track patients' long-term survival [10] [11] [12] .
Analysis
Univariate. ANOVA and the Kruskal-Wallis test were utilized to test for significance. Kaplan-Meier survival curves were constructed for bypass time categorized as <60 min, 60 to <90 min and ≥90 min. The log-rank test was utilized to test significance.
Multivariate. Long-term survival was assessed by stepwise Cox regression analysis. Goodness of fit was assessed using Harrell's c-statistic. In-hospital mortality and the need of resternotomy for bleeding were assessed by stepwise logistic regression analysis. Model accuracy was assessed via the receiver operator curve and the Hosmer-Lemeshow statistic. CKMB release, mediastinal blood loss, ICU length of stay and postoperative length of stay were assessed by stepwise multiple linear regression. Model accuracy was assessed using the residuals (residual plotted by case, residual plotted against a covariate and correlation coefficient). Non-normally distributed data were logged and checked for a normal distribution prior to use of the logged covariate for analysis. The entry criterion was P < 0.05 and the removal criterion was P > 0.1 for multivariate analysis. Covariates analysed included: CPB time, age, sex, body mass index, preoperative renal impairment, diabetes, ejection fraction, preoperative atrial fibrillation and logistic EuroSCORE.
Era of surgery. Owing to advances in perfusion, surgery, and anaesthesia equipment and practices, the study group was divided into two eras, early (before November 2003) and late (November 2003 onwards), and the survival rates were compared to assess a possible era effect (Table 1) .
Risk-adjusted mortality
Risk-adjusted mortality was calculated via the observed death rate divided by the predicted death rate based on EuroSCORE, and multiplied by the institutional death rate for AVR surgery. 
Statistical software
All statistical analysis was performed with MedCalc for Windows (version 12.1.4; MedCalc Software, Mariakerke, Belgium).
RESULTS
A total of 1863 isolated first-time AVR procedures with a crossclamp time <90 min were analysed, with an in-hospital mortality rate of 2.4%. The long-term follow-up rate obtained via the UK national strategic tracing service was 100%.
Univariate CPB time had no significant effect on resternotomy (P = 0.5), CKMB release (P = 0.8) and long-term survival (P = 0.06), but was significantly associated with mediastinal blood loss (P = 0.01), ICU length of stay (P = 0.02), hospital length of stay 
Multivariate
Resternotomy. Logistic regression for resternotomy for bleeding failed to identify any significant factors. Valve haemodynamic pathology was not identified as a significant factor.
Creatinine kinase muscle-brain isoenzyme release. Multiple linear regression for CKMB release identified CPB time (P < 0.001), logistic EuroSCORE (P = 0.001) and preoperative renal impairment (P = 0.003), as significant determining factors (Table 2) . Valve haemodynamic pathology was not identified as a significant factor.
Mediastinal blood loss. Multiple linear regression for mediastinal drainage identified CPB time (P = 0.0003) and preoperative renal impairment (P = 0.04) as significant factors (Table 2 ). Valve haemodynamic pathology was not identified as a significant factor.
Intensive care unit length of stay. Multiple linear regression for ICU length of stay identified CPB time (P = 0.01), logistic EuroSCORE (P < 0.0001) and early era of surgery (P = 0.03) as significant factors (Table 2 ). Valve haemodynamic pathology was not identified as a significant factor.
Postoperative length of stay. Multiple linear regression for postoperative length of stay identified CPB time (P = 0.0002), age (P = 0.001), logistic EuroSCORE (P < 0.0001), diabetes (P = 0.01), preoperative renal impairment (P = 0.02) and early era of surgery (P = 0.0001) as significant factors (Table 2 ). Valve haemodynamic pathology was not identified as a significant factor.
Death. Multiple logistic regression (receiver operating curve = 0.8, Hosmer-Lemeshow, P = 0.1) for death identified CPB time (P = 0.01), age (P = 0.0001), preoperative renal failure (P < 0.0001), preoperative atrial fibrillation (P = 0.04) and New York Heart Association Stage 4
(P = 0.03) as significant factors (Table 3) . EuroSCORE and valve haemodynamic pathology were not identified as significant factors.
Survival. Multiple Cox regression (Harrell's C-statistic 0.6) identified age (P < 0.0001), preoperative renal impairment (P < 0.0001), New York Heart Association Stage 4 (P = 0.02) and valvular incompetence (P = 0.01) as significant factors (Table 4) . Survival at the mean of the covariates for different CPB times is shown in Fig. 3 . If the restriction on cross-clamping to 90 min is removed, CPB time becomes a significant factor (data not shown).
Era of surgery. Multivariate analysis identified that era of surgery had no significant effect on CKMB release (P = 0.2), mediastinal blood loss (P = 0.4) and in-hospital mortality (P = 0.9), but the latter era of this study was significantly associated with a reduced postoperative length of stay (P = 0.03), reduced ICU length of stay (P = 0.0001), reduced resternotomy for bleeding (odds ratio 0.62, 95% CI 0.41-0.94, P = 0.02) and improved long-term survival (hazard ratio 0.76, 95% CI 0.59-0.96, P = 0.02) ( Fig. 4 ; survival plotted at the mean of the covariates by era of surgery). Adjusting for era made no difference with respect to the above study findings.
Risk-adjusted mortality. The risk-adjusted mortality, utilizing an institutional death rate of 2.4%, for a CPB time of <60 min was 0.2 (actual deaths 1 and predicted deaths 11.5), for a CPB time of 60-90 min was 0.4 (actual deaths 9 and predicted deaths 53) and for CPB times >90 min 1.2 (actual deaths 35 and predicted deaths 72.9).
DISCUSSION
Despite improvements over time with regard to morbidity, mortality and long-term survival, CPB time remains a significant factor determining mediastinal blood loss, ICU and hospital length of stay, and in-hospital mortality.
Resternotomy is due to technical failures and coagulopathy. As massive coagulopathy is rare after isolated AVR, it is not surprising that we were unable to determine risk factors for resternotomy. Mediastinal blood loss was significantly affected by CPB time. We speculate, but have no supporting evidence, that the longer the CPB, the greater is the bypass-associated coagulopathy. As this is usually mild, an excess of blood loss through the mediastinal drains occurs without the need for resternotomy. We did not have transfusion data available for the whole study cohort; however, mediastinal blood loss is significantly associated with blood transfusion.
Longer cross-clamp times are associated with a greater risk of myocardial ischaemia, despite the use of cardioplegia [13] . When the cross-clamp time was <90 min, we were still able to identify CPB time as a significant factor determining CKMB release as a surrogate marker of myocardial damage. For periods >90 min of cross-clamp time, CKMB was also significantly associated with raised CKMB levels (data not shown).
ICU length of stay and postoperative length of stay, both of which were significantly associated with CPB time, despite a crossclamp time <90 min, reflect postoperative morbidity and are a major source of direct financial expenditure for a cardiac surgery unit. In addition, a lack of ICU beds has operational implications for most units, causing cancellations.
Death is the main quality marker analysed in cardiac surgery. We have demonstrated that patients with a reduced CPB time have a significantly lower risk of dying after isolated AVR. By including only patients with a cross-clamp time <90 min, we have tried to adjust for technical errors causing increased CPB times and potentially skewing the data. The failure of multivariate analysis to identify logistic EuroSCORE as a significant risk factor confirms previous work identifying it as having poor predictability, sensitivity and specificity in patients undergoing isolated AVR surgery [14] . Owing to the limitations of logistic regression when dealing with a small number of deaths, risk-adjusted mortality was also analysed, which also demonstrated that as CPB time increases, the risk-adjusted mortality also increases.
Long-term survival was not affected by CPB time in this study, however we caution as our study may have been underpowered with regard to the risk of stroke and its effects on survival. If patients with a cross-clamp time >90 min are included, Cox regression identified CPB time as a significant factor determining long-term survival (data not shown), which confirms previous work [11, 15] .
The identification that era of surgery was significantly associated with a reduced postoperative length of stay, reduced ICU length of stay, reduced resternotomy for bleeding and improved longterm survival confirms improvements in perfusion, anaesthetic and surgical practices. Adjusting for era, however, despite these improvements made no difference with respect to the significant effects CPB time has on outcomes. We do not have accurate data on valve and root calcification, and used valve haemodynamic pathology as a surrogate marker for this, as pure regurgitation rarely occurs in calcific valvular disease. Valve pathology had no effect on any of our outcome measures, with the exception of survival, when pure regurgitation was associated with a worse long-term survival. This was not due to endocarditis (data not shown) and we speculate, but offer no supporting data, that an unidentified connective tissue disorder may be an issue.
The availability of rapid deployable valves potentially reduces CPB time [7, 8] . Whether this translates into a reduction in morbidity, mortality and cost savings remains to be determined. We speculate that the benefits of a rapidly deployable valve could potentially be of importance especially in elderly patients undergoing combined AVR and multiple coronary artery bypass grafts. A randomized trial of rapid deployment valves is needed to confirm or refute the findings of this retrospective analysis.
In the modern era, CPB time is a significant risk factor for morbidity and mortality after isolated AVR.
LIMITATIONS
We present a single-institutional retrospective study and it should be interpreted as such due to the inherent errors associated with this methodology. Our logistic regression analysis is potentially underpowered and should be interpreted with caution as we only had 45 deaths, and ideally should have at least 10 outcomes per covariate analysed. We calculated risk-adjusted mortality as a technique to circumvent this. We do not have any long-term morbidity data for our study cohort; however, our study is large and has extended follow-up, which was 100% complete. We do not have data on technical issues during surgery that may have resulted in the longer CPB times in this study. We do not have data on LV hypertrophy and aortic wall calcification, both of which are difficult to quantify, or on the pathology and severity of aortic valve disease. We do not have accurate data on mode of death to allow further analysis. We are unable to distinguish social reasons for discharge from the hospital from medical ones. The ICU length of stay data will not be affected by this. It is unlikely that social issues only affect patients with longer CPB times, thus skewing the data but we cannot disprove this. Owing to the introduction of a computerized blood transfusion service midway through the study period, we do not have a complete transfusion dataset. We do not have blood transfusion data for the whole study period in an electronic format, making interpretation potentially erroneous. We did not have accurate data on valve morphology and utilized valve haemodynamic pathology as a surrogate for this. This enabled the differentiation between calcific disease, which is usually stenotic with or without a regurgitant component, and pure regurgitation, which is rarely calcific in nature. We read with great interest the article by Chalmers et al. on the impact of cardiopulmonary bypass (CPB) time on hospital mortality and in-hospital and intensive care unit length of stay after surgery [1] . It seems very reasonable to study this question based on the example of primary isolated aortic valve replacement. Although sometimes there can be very complicated cases of aortic valve replacement, in general primary aortic valve replacement is a standard and relatively simple cardiac surgical procedure. It helps to minimize the possible impact of complexity and specificity of the procedure itself on postoperative complications. However, the results of the study cannot be considered as unexpected. The longer the CPB time, the greater the time of contact between the patient's blood and the foreign surface of the extracorporeal circuit, the time of blood elements injury, and therefore the severity of the systemic inflammatory response. In addition, there was an increase in the time for potential embolism and in the number of other adverse effects of CPB. It is of note, also, that these results were very similar to those we obtained in our recent study in patients undergoing aortic arch and ascending aorta replacement. We demonstrated a significant association between the CPB time and hospital mortality. However, evaluating the effect of CPB time on the postoperative course was not the purpose of our study. Nevertheless, the result is the result. Using multiple regression analysis, we identified predictors of a complicated postoperative course. Regarding in-hospital postoperative death, such predictors were: resternotomy (OR = 21.156, P = 0.001), prolonged CPB (OR = 5.137, P = 0.023), the need for high doses of cardiotonics at the end of surgery (OR = 4.6, P = 0.031), and prolonged reperfusion time (OR = 3.9,
